Neogen Corporation Revenue and Competitors

Lansing, MI USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Neogen Corporation's estimated annual revenue is currently $503M per year.(i)
  • Neogen Corporation's estimated revenue per employee is $193,372
  • Neogen Corporation's current valuation is $4.2B. (January 2022)

Employee Data

  • Neogen Corporation has 2601 Employees.(i)
  • Neogen Corporation grew their employee count by 9% last year.

Neogen Corporation's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
CEO and PresidentReveal Email/Phone
3
Head Commercial, South & East EuropeReveal Email/Phone
4
Head Talent Acquisition - AmericasReveal Email/Phone
5
VP - Americas & Australia/New ZealandReveal Email/Phone
6
VP Software Product & EngineeringReveal Email/Phone
7
VP, Global OperationsReveal Email/Phone
8
VP Global MarketingReveal Email/Phone
9
VP OperationsReveal Email/Phone
10
VP Digital Solutions MarketingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.9M120%N/AN/A
#2
$2.6M34-56%$31.2MN/A
#3
$0.8M5-44%N/AN/A
#4
$1.9M24100%N/AN/A
#5
$6M39-11%N/AN/A
#6
$4M26-33%N/AN/A
#7
$1.9M120%N/AN/A
#8
$0.8M525%N/AN/A
#9
$14.6M948%N/AN/A
#10
$3.4M225%N/AN/A
Add Company

What Is Neogen Corporation?

Founded in 1982, Neogen Corporation has grown to more than 300 employees in five U.S. and two international locations, and a worldwide presence. The Company, which became a public company in 1989, operates on a fiscal year that begins June 1 and is traded on the NASDAQ Stock Market under the symbol NEOG. The Company's Food Safety Division markets dehydrated culture media and rapid diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, genetic modifications, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals and nutritional supplements. In March 2003, Neogen acquired Adgen Ltd., based in Ayr, Scotland. Adgen provides the Company better access to the European Union, and allows Neogen to better serve its customers and distributors throughout the EU. The acquisition added to Neogen's international presence, and followed the establishment of sales and distribution offices in Shanghai, China, in 2002. In November 2003, Neogen acquired Hacco, Inc. and Hess & Clark. Hacco is a world leading manufacturer of rodenticide products based in Randolph, WI. Some of its more familiar brands include Havoc and Ramik. Hess & Clark was founded over 100 years ago and provides animal safety disinfectants.

keywords:N/A

N/A

Total Funding

2601

Number of Employees

$503M

Revenue (est)

9%

Employee Growth %

$4.2B

Valuation

N/A

Accelerator

Neogen Corporation News

2022-04-20 - Is Neogen Corporation (NEOG) Stock a Good Value?

Neogen Corporation (NEOG) stock is down -43.63% over the last 12 months, and the average rating from Wall Street analysts is a Hold.

2022-04-20 - NEOGEN Genomics Earns CLIA Certificate of Compliance

NEOGEN Corporation develops and markets comprehensive solutions dedicated to food and animal safety, operating with the intention to "everyday,...

2022-03-22 - JOB ALERT: Neogen Corporation is hiring

LANSING, Mich. (WLNS) — Neogen Corporation is hiring a packaging assistant, a shipping clerk, and a quality control tech. Officials say the...

2021-09-28 - NEOGEN : Partners with Hendrix Genetics to Improve Genetic Performance in Africa

LINCOLN, Neb., Sept. 28, 2021 /PRNewswire/ -- NEOGEN Corporation (NASDAQ: NEOG) announced today that they have partnered with Hendrix Genetics, a multi-species animal breeding, genetics, and technology company. Through this partnership, NEOGEN will support the implementation of genomic selectio ...

2021-09-21 - Neogen : Announces Record Revenue in First Quarter

LANSING, Mich., Sept. 21, 2021 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today the results of the first quarter of its 2022 fiscal year, which ended August 31. Revenues were $128,305,000, a 17% increase compared to the previous year's first quarter revenues of $109,325,000. The ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7830M389530%$500M
#2
$2280.8M49678%N/A
#3
$1935.4M51205%N/A
#4
N/A24159N/AN/A